Literature DB >> 11913412

Validation of Spanish language dyspepsia questionnaire.

Jonathan Goldman1, Donald F Conrad, Catherine Ley, David Halperin, Maria de la Luz Sanchez, Rosario Villacorta, Julie Parsonnet.   

Abstract

No dyspepsia-specific questionnaire currently exists in Spanish. The Spanish Language Dyspepsia Questionnaire (SLDQ) was developed based on Rome dyspepsia criteria, other questionnaires, and common symptoms. Self-reported normal and dyspeptic volunteers (N = 63) in Chiapas, Mexico, participated in a validation study. We assessed intra- and interrater reliability by test-retest studies and established validity by both correlation to the Short Form-36 (SF-36) and comparison of scores between normals and dyspeptics. The total SLDQ score showed a wide distribution (range 0-78, mean 23.7 +/- 21.9). Internal reliability of the SLDQ was high (Cronbach's a = 0.93). Intra- and interrater reliability were excellent (scores from the first and second interviews not statistically different; P = 0.94; intraclass correlation coefficient = 0.96). SLDQ scales correlated appropriately with the SF-36. The SLDQ distinguished self-classified normals from dyspeptics (P < 0.001). The SLDQ fills the unmet need for a valid, reproducible, and multidimensional Spanish-language instrument to measure dyspepsia. Additionally, we have made suggestions for the development of symptom-quantifying questionnaires.

Entities:  

Mesh:

Year:  2002        PMID: 11913412     DOI: 10.1023/a:1017936623783

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  25 in total

1.  Somatic symptoms of distress: an international primary care study.

Authors:  G Simon; R Gater; S Kisely; M Piccinelli
Journal:  Psychosom Med       Date:  1996 Sep-Oct       Impact factor: 4.312

2.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

3.  Dyspepsia: how should we measure it?

Authors:  D H Kuykendall; L Rabeneck; C J Campbell; N P Wray
Journal:  J Clin Epidemiol       Date:  1998-02       Impact factor: 6.437

4.  Validity of a new quality of life scale for functional dyspepsia: a United States multicenter trial of the Nepean Dyspepsia Index.

Authors:  N J Talley; M Verlinden; M Jones
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

5.  A systematic overview (meta-analysis) of outcome measures in Helicobacter pylori gastritis trials and functional dyspepsia.

Authors:  S J Veldhuyzen van Zanten
Journal:  Scand J Gastroenterol Suppl       Date:  1993

Review 6.  A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia.

Authors:  N J Talley
Journal:  Gastroenterology       Date:  1994-05       Impact factor: 22.682

7.  Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens?

Authors:  E Dimenäs; H Glise; B Hallerbäck; H Hernqvist; J Svedlund; I Wiklund
Journal:  Scand J Gastroenterol       Date:  1993-08       Impact factor: 2.423

8.  The Leeds Dyspepsia Questionnaire: a valid tool for measuring the presence and severity of dyspepsia.

Authors:  P Moayyedi; S Duffett; D Braunholtz; S Mason; I D Richards; A C Dowell; A T Axon
Journal:  Aliment Pharmacol Ther       Date:  1998-12       Impact factor: 8.171

9.  What is behind dyspepsia?

Authors:  A G Klauser; W A Voderholzer; P A Knesewitsch; N E Schindlbeck; S A Müller-Lissner
Journal:  Dig Dis Sci       Date:  1993-01       Impact factor: 3.199

Review 10.  Helicobacter pylori and dyspepsia.

Authors:  N J Talley
Journal:  Yale J Biol Med       Date:  1999 Mar-Jun
View more
  1 in total

1.  A validation study of the Italian Short-Form Leeds Dyspepsia Questionnaire.

Authors:  Luigi Gatta; Paul Moayyedi; Cesare Tosetti; Nimish Vakil; Enzo Ubaldi; Patrizia Barsanti; Giulia Fiorini; Valentina Castelli; Carlo Gargiulo; Paolo Lucarini; Maurizio Lera; Enkleda Kajo; Francesco Di Mario; Dino Vaira
Journal:  Intern Emerg Med       Date:  2010-10-01       Impact factor: 3.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.